Antibody Treatments May Be the Best Hope Against the Virus Until a Vaccine

Neutralizing those spikes may be the best way to prevent the virus from harming its host. And among the most promising approaches to doing that is finding the right antibodies. Multiple companies are doing this, using antibodies from laboratory mice and recovered patients. Unlike existing medicines being tested on the virus—such as hydroxychloroquine, the malaria drug controversially touted by President Trump, and remdesivir, an antiviral compound originally developed by Gilead Sciences Inc. to fight Ebola—antibody drugs are being designed specifically to disable the new virus where it’s most vulnerable.


About Giorgio Bertini

Research Professor. Founder Director at Learning Change Project - Research on society, culture, art, neuroscience, cognition, critical thinking, intelligence, creativity, autopoiesis, self-organization, rhizomes, complexity, systems, networks, leadership, sustainability, thinkers, futures ++
This entry was posted in Coronavirus, COVID-19 and tagged , . Bookmark the permalink.